Myriam Sainz-Ramos

Mrs. Myriam Sainz-Ramos

NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV-EHU), Vitoria-Gasteiz, Spain.
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SGSantiago Grijalvo
Santiago Grijalvo
GPGustavo Puras
Gustavo Puras
JZJon Zárate
Jon Zárate
MSMyriam Sainz-Ramos
Myriam Sainz-Ramos
NQNuseibah AL Qtaish
Nuseibah AL Qtaish
Ramon EritjaRamon Eritja
Ramon Eritja
Cationic niosomes have become important non-viral vehicles for transporting a good number of small drug molecules and macromolecules. Growing interest shown by these colloidal nanoparticles in therapy is determined by their structural similarities to liposomes. Cationic niosomes are usually obtained from the self-assembly of non-ionic surfactant molecules. This process can be governed not only by the nature of such surfactants but also by others factors like the presence of additives, formulation preparation and properties of the encapsulated hydrophobic or hydrophilic molecules. This review is aimed at providing recent information for using cationic niosomes for gene delivery purposes with particular emphasis on improving the transportation of antisense oligonucleotides (ASOs), small interference RNAs (siRNAs), aptamers and plasmids (pDNA).

Verified
Journal Article
Open access
PDF file
MSMyriam Sainz-Ramos
Myriam Sainz-Ramos
IGIdoia Gallego
Idoia Gallego
Ilia Villate-BeitiaIlia Villate-Beitia
Ilia Villate-Beitia
JZJon Zarate
Jon Zarate
IPIván Maldonado Pérez
Iván Maldonado Pérez
José Luis PedrazJosé Luis Pedraz
José Luis Pedraz
Efficient delivery of genetic material into cells is a critical process to translate gene therapy into clinical practice. In this sense, the increased knowledge acquired during past years in the molecular biology and nanotechnology fields has contributed to the development of different kinds of non-viral vector systems as a promising alternative to virus-based gene delivery counterparts. Consequently, the development of non-viral vectors has gained attention, and nowadays, gene delivery mediated by these systems is considered as the cornerstone of modern gene therapy due to relevant advantages such as low toxicity, poor immunogenicity and high packing capacity. However, despite these relevant advantages, non-viral vectors have been poorly translated into clinical success. This review addresses some critical issues that need to be considered for clinical practice application of non-viral vectors in mainstream medicine, such as efficiency, biocompatibility, long-lasting effect, route of administration, design of experimental condition or commercialization process. In addition, potential strategies for overcoming main hurdles are also addressed. Overall, this review aims to raise awareness among the scientific community and help researchers gain knowledge in the design of safe and efficient non-viral gene delivery systems for clinical applications to progress in the gene therapy field.

25 February 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NQNuseibah AL Qtaish
Nuseibah AL Qtaish
IGIdoia Gallego
Idoia Gallego
Ilia Villate-BeitiaIlia Villate-Beitia
Ilia Villate-Beitia
MSMyriam Sainz-Ramos
Myriam Sainz-Ramos
TLTania Belén López-Méndez
Tania Belén López-Méndez
José Luis PedrazJosé Luis Pedraz
José Luis Pedraz
Non-viral vectors have emerged as a promising alternative to viral gene delivery systems due to their safer profile. Among non-viral vectors, recently, niosomes have shown favorable properties for gene delivery, including low toxicity, high stability, and easy production. The three main components of niosome formulations include a cationic lipid that is responsible for the electrostatic interactions with the negatively charged genetic material, a non-ionic surfactant that enhances the long-term stability of the niosome, and a helper component that can be added to improve its physicochemical properties and biological performance. This review is aimed at providing recent information about niosome-based non-viral vectors for gene delivery purposes. Specially, we will discuss the composition, preparation methods, physicochemical properties, and biological evaluation of niosomes and corresponding nioplexes that result from the addition of the genetic material onto their cationic surface. Next, we will focus on the in situ application of such niosomes to deliver the genetic material into immune-privileged tissues such as the brain cortex and the retina. Finally, as future perspectives, non-invasive administration routes and different targeting strategies will be discussed.

28 October 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
FGFátima García-Villén
Fátima García-Villén
Sandra Ruiz-AlonsoSandra Ruiz-Alonso
Sandra Ruiz-Alonso
MLMarkel Lafuente-Merchan
Markel Lafuente-Merchan
IGIdoia Gallego
Idoia Gallego
MSMyriam Sainz-Ramos
Myriam Sainz-Ramos
José Luis PedrazJosé Luis Pedraz
José Luis Pedraz
The adaptation and progress of 3D printing technology toward 3D bioprinting (specifically adapted to biomedical purposes) has opened the door to a world of new opportunities and possibilities in tissue engineering and regenerative medicine. In this regard, 3D bioprinting allows for the production of tailor-made constructs and organs as well as the production of custom implants and medical devices. As it is a growing field of study, currently, the attention is heeded on the optimization and improvement of the mechanical and biological properties of the so-called bioinks/biomaterial inks. One of the strategies proposed is the use of inorganic ingredients (clays, hydroxyapatite, graphene, carbon nanotubes and other silicate nanoparticles). Clays have proven to be useful as rheological and mechanical reinforcement in a wide range of fields, from the building industry to pharmacy. Moreover, they are naturally occurring materials with recognized biocompatibility and bioactivity, revealing them as optimal candidates for this cutting-edge technology. This review deals with the use of clays (both natural and synthetic) for tissue engineering and regenerative medicine through 3D printing and bioprinting. Despite the limited number of studies, it is possible to conclude that clays play a fundamental role in the formulation and optimization of bioinks and biomaterial inks since they are able to improve their rheology and mechanical properties, thus improving printability and construct resistance. Additionally, they have also proven to be exceptionally functional ingredients (enhancing cellular proliferation, adhesion, differentiation and alignment), controlling biodegradation and carrying/releasing actives with tissue regeneration therapeutic activities.

15 March 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
NQNuseibah AL Qtaish
Nuseibah AL Qtaish
IGIdoia Gallego
Idoia Gallego
Alejandro ParedesAlejandro Paredes
Alejandro Paredes
Ilia Villate-BeitiaIlia Villate-Beitia
Ilia Villate-Beitia
CSCristina Soto-Sánchez
Cristina Soto-Sánchez
José Luis PedrazJosé Luis Pedraz
José Luis Pedraz
Nanodiamonds (NDs) are promising materials for gene delivery because of their unique physicochemical and biological features, along with their possibility of combination with other nonviral systems. Our aim was to evaluate the biophysical performance of NDs as helper components of niosomes, named nanodiasomes, to address a potential nonviral gene delivery nanoplatform for therapeutic applications in central nervous system (CNS) diseases. Nanodiasomes, niosomes, and their corresponding complexes, obtained after genetic material addition at different ratios (w/w), were evaluated in terms of physicochemical properties, cellular uptake, intracellular disposition, biocompatibility, and transfection efficiency in HEK-293 cells. Nanodiasomes, niosomes, and complexes fulfilled the physicochemical features for gene therapy applications. Biologically, the incorporation of NDs into niosomes enhanced 75% transfection efficiency (p < 0.001) and biocompatibility (p < 0.05) to values over 90%, accompanied by a higher cellular uptake (p < 0.05). Intracellular trafficking analysis showed higher endocytosis via clathrins (p < 0.05) in nanodiaplexes compared with nioplexes, followed by higher lysosomal colocalization (p < 0.05), that coexisted with endosomal escape properties, whereas endocytosis mediated by caveolae was the most efficient pathway in the case of nanodiaplexes. Moreover, studies in CNS primary cells revealed that nanodiaplexes successfully transfected neuronal and retinal cells. This proof-of-concept study points out that ND integration into niosomes represents an encouraging nonviral nanoplatform strategy for the treatment of CNS diseases by gene therapy.

1 October 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MSMyriam Sainz-Ramos
Myriam Sainz-Ramos
Ilia Villate-BeitiaIlia Villate-Beitia
Ilia Villate-Beitia
IGIdoia Gallego
Idoia Gallego
NQNuseibah A.L. Qtaish
Nuseibah A.L. Qtaish
TLTania B. Lopez-Mendez
Tania B. Lopez-Mendez
José Luis PedrazJosé Luis Pedraz
José Luis Pedraz